Home > Products > CD317 & CD16 > Recombinant Human Anti-CD317 x Human Anti-CD16 Bispecific Antibody (scFv-CH1/CL)

Recombinant Human Anti-CD317 x Human Anti-CD16 Bispecific Antibody (scFv-CH1/CL)  (CAT#: BSCC-H287)

Recombinant Anti-CD317 x Anti-CD16 Bispecific Antibody (scFv-CH1/CL) is designed to be expressed as two chains. One scFv from an anti-CD317 antibody variable domain is fused to CH1 and the other scFv from an anti-CD16 antibody variable domain fused to CL, or vice versa. And the CH1 and CL domains are linked covalently via a natural disulfide bond. This BsAb can retarget NK cells to tumor cells. It is designed for the research of Multiple myeloma (MM) therapy.
Datasheet INQUIRY

Specifications

Targets
CD317 & CD16
Type
scFv-based Bispecific Fragments
Species Reactivity
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Multiple myeloma (MM)

Targets

Target 1
CD317
Gene ID
UniProt ID
Alternative Names
CD317; TETHERIN; BST2; bone marrow stromal cell antigen 2; Cluster of differentiation 317
Target 2
CD16
Gene ID
UniProt ID
Alternative Names
FCGR3A; Fc fragment of IgG, low affinity IIIa, receptor (CD16a); CD16; FCG3; CD16A; FCGR3; IGFR3; IMD20; FCR-10; FCRIII; FCGRIII; FCRIIIA; low affinity immunoglobulin gamma Fc region receptor III-A; FcγRIII; FcgammaRIIIA; CD16a antigen; fc-gamma RIII; Fc-gamma RIIIa; Fc-gamma RIII-alpha; igG Fc receptor III-2; Fc gamma receptor III-A; Fc-gamma receptor IIIb (CD16); neutrophil-specific antigen NA; Fc-gamma receptor III-2 (CD 16); immunoglobulin G Fc receptor III; Fc fragment of IgG, low affinity III, receptor for (CD16)
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

Related products of "CD317 & CD16"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-CD317 x Human Anti-CD16 Bispecific Antibody (scFv-CH1/CL) (BSCC-H287). Click the button below to contact us or submit your feedback about this product.